A new study shows that the emergency-authorized drug for COVID-19, molnupiravir, can induce hundreds of mutations in immune-compromised people.[1] Molnupiravir (Lagevrio) works by causing mutations in the genome of SARS-CoV-2 to produce an ‘error catastrophe’ to stop its replication. A five-day course of 40 capsules taken as four capsules twice daily for five days cost…
Molnupiravir Causes Hundred of SARS-CoV-2 Mutations
Posted on